EXPLANATORY NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.-Up Agreement • August 16th, 2021 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances) • England and Wales
THIS RESERVATION AND START-UP AGREEMENT (“Agreement”), effective as of the date of execution by the last party to sign below (the “Effective Date”) is by and between hVIVO Services Limited, a company registered in England (company registration number 02326557) whose registered office is at QMB Innovation Centre, 42 New Road, London E1 2AX, UK (“hVIVO”) and AIM ImmunoTech Inc., a company incorporated in Delaware, USA, whose registered office or principle place of business is at 2117 SW Highway 484 Ocala, FL 34473, USA (“Sponsor”).
Supplementary Agreement (II)Supplementary Agreement • August 16th, 2021 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances)
Further and pursuant to the Material Transfer and Research Agreement the Parties agree to extend the duration of the Agreement by a period of twenty-four (24) months until 31 May 2023. All other terms and conditions under the agreement shall remain unchanged.
Supplementary Agreement (II)Supplementary Agreement • August 16th, 2021 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances)
Further and pursuant to the Material Transfer and Research Agreement the Parties agree to extend the duration of the Agreement by a period of twenty-four (24) months until 31 May 2023. All other terms and conditions under the agreement shall remain unchanged.
